Coll2-1 in viscosupplementation: results form Epikart study
Artialis' biomarker Coll2-1 and viscosupplementation of hyaluronic acid: results from EPIKART, a Pilot Prospective Comparative Randomized Double Blind Trial.
New Job opportunity
Artialis is seeking for a Junior Administrative Assistante.
Meet us in Spain - EULAR 2017
We kindly invite you to meet us during the EULAR 2017 Congress.
“We chose Artialis because of their expertise in the design of in vivo protocol specialized in osteoarthritis. Moreover, it was very well written and Artialis team inspired a lot of confidence.
[We liked] their dedication to our project, their knowledge in osteoarthritis, their access to a state of the art animal facility, [and] their knowledge in in vivo design protocol (…) I would highly recommend the services of Artialis mainly for their high quality and high involvement.”
R&D Project Manager, Confidential Customer
We needed a specific measure for the cartilage degeneration to prove the efficacy of our product. The collaboration with Artialis was a logical choice
Sales & Marketing Director, Tilman (Belgium)
Since the biomarker world is very competitive, every work involving new biomarkers should be previously and accurately discussed to tune the interests of the Sponsor with those of Artialis.
They are on time and flexible [and have] the ability to focus rapidly on the Sponsor requirement.
[We appreciate the] reliability of data and the open and timely communication.
Director Pharmacology & Toxicology, Rottapharm Biotech